| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Charles N. Mills is Director at MDLN. Charles N. Mills's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.7M at current prices.
Net of sales, the MDLN filings show accumulation of 2,579,310 shares.
Charles N. Mills has 1 Form 4 filing on record in December 2025, as Director at Medline (MDLN), 2025.
The 4 reported transactions were 2 open-market purchases, 1 stock award and 1 option or other derivative award.
Counted by filing, the open-market trades come to 1 purchase worth about $74.8M and no sales.
The only open-market purchase was 2,579,310 shares of MDLN at an average $29.00 on December 18, 2025, about $74.8M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | MDLN Medline Inc. | Director | Buy | 2,579,310 | $29.00 | $74,799,990.00 | -105.6% | +7.0% | - |